458 filings
Page 4 of 23
144
Dana Pizzuti
3 Jan 24
Notice of proposed sale of securities
4:11pm
144
CRNX
Crinetics Pharmaceuticals Inc
2 Jan 24
Notice of proposed sale of securities
4:44pm
4
Stephen F. Betz
27 Dec 23
Crinetics Pharmaceuticals / Stephen F. Betz ownership change
5:20pm
144
Stephen F. Betz
26 Dec 23
Notice of proposed sale of securities
11:47am
4
Dana Pizzuti
22 Dec 23
Crinetics Pharmaceuticals / Dana Pizzuti ownership change
6:45pm
144
Dana Pizzuti
21 Dec 23
Notice of proposed sale of securities
5:28pm
8-K
CRNX
Crinetics Pharmaceuticals Inc
18 Dec 23
Crinetics Announces Positive Initial Findings from Ongoing Open-Label Phase 2 Study of Paltusotine for the Treatment of Carcinoid Syndrome
4:12pm
144
CRNX
Crinetics Pharmaceuticals Inc
14 Dec 23
Notice of proposed sale of securities
4:37pm
4
Stephen F. Betz
13 Dec 23
Crinetics Pharmaceuticals / Stephen F. Betz ownership change
4:44pm
8-K
CRNX
Crinetics Pharmaceuticals Inc
12 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:35pm
144
Stephen F. Betz
11 Dec 23
Notice of proposed sale of securities
1:48pm
4
Stephen F. Betz
29 Nov 23
Crinetics Pharmaceuticals / Stephen F. Betz ownership change
4:31pm
144
Stephen F. Betz
27 Nov 23
Notice of proposed sale of securities
11:40am
4
Struthers Richard Scott
13 Nov 23
Crinetics Pharmaceuticals / Richard Scott Struthers ownership change
4:33pm
S-8
CRNX
Crinetics Pharmaceuticals Inc
7 Nov 23
Registration of securities for employees
4:31pm
10-Q
2023 Q3
CRNX
Crinetics Pharmaceuticals Inc
Quarterly report
7 Nov 23
4:11pm
8-K
CRNX
Crinetics Pharmaceuticals Inc
7 Nov 23
Crinetics Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:04pm
4
Struthers Richard Scott
6 Nov 23
Crinetics Pharmaceuticals / Richard Scott Struthers ownership change
6:02pm
4
Marc Wilson
3 Nov 23
Crinetics Pharmaceuticals / Marc Wilson ownership change
7:38pm
144
Struthers Richard Scott
3 Nov 23
Notice of proposed sale of securities
4:00pm